CSPG4 and cancer: To improve the efficacy of this anti-cancer vaccine, the possibility of combining anti-CSPG4 DNA vaccination with ICIs for the treatment of OMM could be an interesting new therapeutic option for canine patients' management, being also of precious translational value for the human context.